A carregar...
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad
The aim of this review was to summarize the evidence for combination therapy to achieve serum urate (SUA) target levels in gout. Within this overarching aim, a second aim was to evaluate the evidence for a new uricosuric agent lesinurad, which inhibits urate transport in the kidney. In summary, this...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661481/ https://ncbi.nlm.nih.gov/pubmed/29123379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S97959 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|